Section
Policy
IRA, state PBM reform, Medicare, and regulatory action
Policy
Gilead plans to supply Yeztugo to 3M people through 2028 via Global Fund partnerships, but MSF calls the scale…
Policy
Reclassification of 12 unapproved peptides ahead of a July advisory meeting marks a sharp policy turn, raising…
PolicySTAT News ↗
New research questions GLP-1's purpose, a pancreatic cancer breakthrough, and more biotech news from The Reado…
PolicySTAT News ↗
“When health care infrastructure is attacked and held for ransom by hackers, patients become real casualties,”…
PolicySTAT News ↗
Despite some headlines, a new poll does not show that most Americans no longer trust vaccines.…
PolicySTAT News ↗
The ruling delivers clarity on the path forward for addressing problems with the No Surprises Act.…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.